IRLAB Obtains Regulatory Approval to Conduct Phase IIb Study With Pirepemat – One Step Closer To Improving Balance and Reducing Fall Injuries For People Living With Parkinson’s Disease
GOTHENBURG, SWEDEN / ACCESSWIRE / December 22, 2021 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA)IRLAB (Nasdaq Stockholm: IRLAB A) IRLAB receives regulatory...